Who Exports Albendazole from India — 628 Suppliers Behind a $72.5M Market
India's albendazole export market is supplied by 628 active exporters who collectively shipped $72.5M across 6,340 shipments. MEPRO PHARMACEUTICALS PRIVATE LIMITED leads with a 13.6% market share, followed by MEDOPHARM and IPCA LABORATORIES LIMITED. The top 5 suppliers together control 39.4% of total export value, reflecting a moderately competitive market structure.
Top Albendazole Exporters from India — Ranked by Export Value
MEPRO PHARMACEUTICALS PRIVATE LIMITED is the leading albendazole exporter from India, holding a 13.6% share of the $72.5M market across 6,340 shipments from 628 exporters. The top 5 suppliers — MEPRO PHARMACEUTICALS PRIVATE LIMITED, MEDOPHARM, IPCA LABORATORIES LIMITED, GRACURE PHARMACEUTICALS LIMITED, CAPLIN POINT LABORATORIES LIMITED — collectively control 39.4% of total export value, indicating a competitive market. Individual shares are: MEPRO PHARMACEUTICALS PRIVATE LIMITED (13.6%), MEDOPHARM (7.3%), IPCA LABORATORIES LIMITED (7.2%), GRACURE PHARMACEUTICALS LIMITED (5.8%), CAPLIN POINT LABORATORIES LIMITED (5.4%).
Top Albendazole Exporters from India
Ranked by export value · 628 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MEPRO PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS: ALBENDAZOLE CHEALBENDAZOLE TABLETS USP 400MG (70000 X 1ALBENDAZOLE TABLETS USP 400MG 93300 X 1 | $9.9M | 15 | 13.6% |
| 2 | MEDOPHARM PHARMACEUTICAL PRODUCTS: ALBENDAZOLE CHECALBEN ( ALBENDAZOLE CHEWABLE TABLETS 40VERZOL SUSPENSION B/10 ML (ALBENDAZOLE U | $5.3M | 16 | 7.3% |
| 3 | IPCA LABORATORIES LIMITED HARMLESS MEDICINES NEMOZOLE 400MG TABLETS ALBENDAZOLE 1X5SHARMLESS MEDICINES:NEMOZOLE-400MG TABLETSR.B.D: ALBENDAZOLENEMOZOLE-400MG TABLETS | $5.2M | 5 | 7.2% |
| 4 | GRACURE PHARMACEUTICALS LIMITED PHARMACEUTICAL PRODUCTS: ALBENDAZOLE CHEVERZOL SUSPENSION B/10 ML (ALBENDAZOLE UVERZOL SUSPENSION B/10 ML | $4.2M | 5 | 5.8% |
| 5 | CAPLIN POINT LABORATORIES LIMITED CALBEN ( ALBENDAZOLE CHEWABLE TABLETS 40ALBENDAZOLE TABLETS 400 MG (ALBENDAZOLEABZ TABLETS 1 S, PACK OF - 1 | $3.9M | 11 | 5.4% |
| 6 | INDOCO REMEDIES LIMITED ALBENDAZOLE TABLETS 400 MG (ALBENDAZOLEABZ TABLETS 1 S, PACK OF - 1 | $3.6M | 11 | 5.0% |
| 7 | MICRO LABS LIMITED ALBENDAZOLE ORAL SUSPENSION BP 100MG/5MLALBENDAZOLE 400 MG. TABLET 50 X 2 PAC (ALDAZ (ALBENDAZOLE CHEWABLE TABLETS 400 | $2.2M | 12 | 3.0% |
| 8 | LINCOLN PHARMACEUTICALS LTD ALBENDAZOLE 400 MG. TABLET 50 X 2 PAC (ALDAZ (ALBENDAZOLE CHEWABLE TABLETS 400DISWORM ALBENDAZOLE 200 MG/5 ML SUSPENSION 1X10 ML | $1.7M | 13 | 2.4% |
| 9 | KROSYL PHARMACEUTICALS PRIVATE LIMITED ALBENDAZOLE ORAL SUSPENSION BP 100MG/5MLALBENDAZOLE CHEWABLE TABLETS 400 MG (100ALBENDAZOLE 2500MG BOLUS | $1.7M | 1 | 2.3% |
| 10 | LEBEN LABORATORIES PRIVATE LIMITED ALBENDAZOLE 400 MG. TABLET 50 X 2 PAC (ALDAZ (ALBENDAZOLE CHEWABLE TABLETS 400DISWORM ALBENDAZOLE 200 MG/5 ML SUSPENSION 1X10 ML | $1.7M | 7 | 2.3% |
| 11 | BRAWN LABORATORIES LIMITED ALBENDAZOLE 400 MG. TABLET 50 X 2 PAC (ALDAZ (ALBENDAZOLE CHEWABLE TABLETS 400DISWORM ALBENDAZOLE 200 MG/5 ML SUSPENSION 1X10 ML | $1.4M | 11 | 1.9% |
| 12 | CIPLA LIMITED ALBENDAZOLE TABLETS 400 MG (ALBENDAZOLEABZ TABLETS 1 S, PACK OF - 1 | $1.2M | 7 | 1.7% |
| 13 | ZIM LABORATORIES LIMITED. ALBENDAZOLE 400 MG. TABLET 50 X 2 PAC (ALDAZ (ALBENDAZOLE CHEWABLE TABLETS 400DISWORM ALBENDAZOLE 200 MG/5 ML SUSPENSION 1X10 ML | $1.1M | 4 | 1.6% |
| 14 | MEDICO REMEDIES LIMITED | $1.0M | 7 | 1.4% |
| 15 | SCOTT EDIL PHARMACIA LIMITED ALBENDAZOLE 400 MG. TABLET 50 X 2 PAC (ALDAZ (ALBENDAZOLE CHEWABLE TABLETS 400DISWORM ALBENDAZOLE 200 MG/5 ML SUSPENSION 1X10 ML | $958.2K | 10 | 1.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Albendazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MEPRO PHARMACEUTICALS PRIVATE LIMITED | Not Listed | Yes, March 2023 | No | Not verified | WHO-GMP certified in March 2023. (extranet.who.int) |
| MEDOPHARM | Not Listed | Yes, January 2025 | No | Not verified | WHO-GMP certified in January 2025. (extranet.who.int) |
| IPCA LABORATORIES LIMITED | Not Listed | Yes, June 2023 | No | Not verified | WHO-GMP certified in June 2023. (extranet.who.int) |
| MICRO LABS LIMITED | Not Listed | Yes, August 2024 | No | Not verified | WHO-GMP certified in August 2024. (extranet.who.int) |
| INDOCO REMEDIES LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certified. |
| CIPLA LIMITED | Approved | Yes | No | 1 | FDA approval for Acyclovir Cream, 5% in May 2025. |
| LINCOLN PHARMACEUTICALS LTD | Not Listed | Yes | No | Not verified | WHO-GMP certified. |
| ZIM LABORATORIES LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certified. |
TransData Nexus reviewed the regulatory standing of 8 leading Albendazole exporters from India. 1 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Albendazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous API manufacturers, including those producing Albendazole. Companies like Rakshit Drugs, established in 2000, have been instrumental in developing and supplying high-quality APIs and intermediates, partnering with leading pharmaceutical firms globally. The presence of such manufacturers underscores Hyderabad's critical role in the Albendazole supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Alembic Pharmaceuticals, headquartered in Vadodara, exemplifies this specialization. Founded in 1907, Alembic has evolved into a multinational entity, producing a wide range of pharmaceutical products, including formulations for various therapeutic areas. This region's focus on formulations complements the API production in other clusters, facilitating a seamless transition from raw materials to finished products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceuticals. Ipca Laboratories, based in Mumbai, is a significant player in this region. Established in 1949, Ipca manufactures APIs and formulations, exporting to over 120 countries. The strategic location of this cluster, coupled with robust infrastructure, facilitates efficient distribution of Albendazole to international markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives. This region hosts numerous manufacturing units, contributing significantly to the production of various pharmaceutical products. The tax benefits and supportive policies have attracted substantial investment, enhancing the region's capacity to produce and supply medications like Albendazole.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Assess Supplier Capabilities: Evaluate potential suppliers' manufacturing capacities, quality certifications, and compliance with international standards to ensure consistent product quality.
- Leverage Export Hubs: Utilize the Mumbai-Thane-Raigad cluster's infrastructure for efficient international distribution of Albendazole.
- Monitor Regulatory Changes: Stay informed about policy shifts, especially in tax incentive zones like Baddi-Nalagarh, to optimize sourcing strategies.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can enhance its Albendazole supply chain, ensuring reliability and quality in its offerings.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Albendazole exporters from India
IPCA Laboratories Limited — IPCA Laboratories acquires 33.38% stake in Unichem Laboratories
On April 24, 2023, IPCA Laboratories Limited entered into a Share Purchase Agreement to acquire 33.38% of Unichem Laboratories Limited's equity share capital. This acquisition is subject to regulatory approvals, including from the Competition Commission of India. - IMPACT: This strategic acquisition is expected to enhance IPCA's manufacturing capabilities and may positively influence its Albendazole export capacity.
Impact: This strategic acquisition is expected to enhance IPCA's manufacturing capabilities and may positively influence its Albendazole export capacity.
Sai Life Sciences Limited — Sai Life Sciences acquires 74.64% stake in Noumed Pharmaceuticals
In October 2025, Sai Life Sciences Limited, through its wholly owned subsidiary Sai Parenterals Pte Limited, entered into a Share Purchase Agreement to acquire a 74.64% stake in Noumed Pharmaceuticals Pty Limited, an Australian pharmaceutical company. The acquisition aims to expand Sai Life Sciences' presence in regulated markets and enhance its manufacturing capacity. - IMPACT: While not directly related to Albendazole, this acquisition may bolster Sai Life Sciences' overall export capabilities, potentially affecting the competitive landscape for Albendazole exports.
Impact: While not directly related to Albendazole, this acquisition may bolster Sai Life Sciences' overall export capabilities, potentially affecting the competitive landscape for Albendazole exports.
Cipla Limited — Cipla divests stake in Cipla Medpro Holdings
On August 25, 2022, Cipla Limited dissolved its subsidiary, Cipla Medpro Holdings (Pty) Limited, as part of its strategic realignment. (uploads2.craft.co) - IMPACT: This divestiture may allow Cipla to reallocate resources, potentially impacting its focus on Albendazole production and exports.
Impact: This divestiture may allow Cipla to reallocate resources, potentially impacting its focus on Albendazole production and exports.
Common Questions — Albendazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which albendazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MEPRO PHARMACEUTICALS PRIVATE LIMITED leads with 98 recorded shipments worth $9.9M. MEDOPHARM (108 shipments) and IPCA LABORATORIES LIMITED (230 shipments) are also established high-volume exporters.
Q How many albendazole manufacturers are there in India?
India has 628 active albendazole exporters with a combined export market of $72.5M across 6,340 shipments to 150 countries. The top 5 suppliers hold 39.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for albendazole from India?
Average FOB unit price: $2.84 per unit, ranging from $0.00 to $1571.39. Average shipment value: $11.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 628 verified Indian exporters of Albendazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 6,340 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 150 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,340 Verified Shipments
628 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists